| Literature DB >> 16335066 |
John P Santell1, Diane D Cousins.
Abstract
Confusion arising from product naming practices can result in unauthorized drug and improper dose/quantity errors. Efforts by FDA, drug manufacturers, pharmacists, other health care professionals, and patients can reduce the risk of these errors.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16335066 DOI： 10.1016/s1553-7250(05)31083-x
Source DB: PubMed Journal: Jt Comm J Qual Patient Saf ISSN： 1553-7250